MIGRAINE

RESEARCH STUDY

Consider enrolling in a clinical research study and help us learn more about migraine treatments

The CHALLENGE-MIG Study is a clinical research study comparing two approved medications for the prevention of episodic migraine. This study will address a gap in the information needed by patients with episodic migraine. It will also help healthcare providers make informed decisions regarding migraine prevention treatment.

The study is being conducted by Ventavia Research Group in Keller and Ft. Worth.

You, or someone you know, may be able to take part if you/they:

• Are 18 to 65 years of age
• Have been diagnosed with migraine
• Have a history of migraine  headaches of at least 1 year

What else do I need to consider?

• The study team will explain the possible benefits and risks of the study.
• You do not have to take part in the study if you do not want to.
• If you choose to take part in the study, you can stop participating at any time.
• You will not be paid to take part in this study, but you may be reimbursed for reasonable travel costs during your participation.
• The study medication and all study-related tests will be provided at no cost to you.
• A team of doctors and nurses will monitor your health carefully during the study.
• The study has been approved by an Institutional Review Board (IRB), which protects the rights, safety, and well-being of the participants.